These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9533640)

  • 21. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.
    Johnson NJ; Rodgers RJ
    Psychopharmacology (Berl); 1996 Apr; 124(4):355-64. PubMed ID: 8739551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effect of ethanol on anxiety and 5-HT in the prefrontal cortex of rats.
    Langen B; Dietze S; Fink H
    Alcohol; 2002 Jun; 27(2):135-41. PubMed ID: 12106833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
    Altar CA; Boyar WC
    Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
    Lanza M; Makovec F
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):33-8. PubMed ID: 10651144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
    Fossa AA; DePasquale MJ; Morrone J; Zorn SH; Bryce D; Lowe JA; McLean S
    J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted mutation of CCK(2) receptor gene antagonises behavioural changes induced by social isolation in female, but not in male mice.
    Abramov U; Raud S; Kõks S; Innos J; Kurrikoff K; Matsui T; Vasar E
    Behav Brain Res; 2004 Nov; 155(1):1-11. PubMed ID: 15325774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze.
    Lin D; Parsons LH
    Pharmacol Biochem Behav; 2002 Apr; 71(4):581-7. PubMed ID: 11888549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant increase in the aggressive behavior of transgenic mice overexpressing peripheral progastrin peptides: associated changes in CCK2 and serotonin receptors in the CNS.
    Li Q; Deng X; Singh P
    Neuropsychopharmacology; 2007 Aug; 32(8):1813-21. PubMed ID: 17228339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.
    Chopin P; Briley M
    Psychopharmacology (Berl); 1993; 110(4):409-14. PubMed ID: 7870910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
    Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
    Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCK-8S facilitates 5-HT release in the rat hypothalamus.
    Voigt JP; Sohr R; Fink H
    Pharmacol Biochem Behav; 1998 Jan; 59(1):179-82. PubMed ID: 9443553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of CCK-induced aversion in rats on the elevated x-maze by the selective 5-HT1A receptor antagonists (+) WAY100135 and WAY100635.
    Bickerdike MJ; Fletcher A; Marsden CA
    Neuropharmacology; 1995 Jul; 34(7):805-11. PubMed ID: 8532148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels.
    Kõks S; Vasar E; Soosaar A; Lang A; Volke V; Võikar V; Bourin M; Männistö PT
    Eur Neuropsychopharmacol; 1997 Nov; 7(4):289-94. PubMed ID: 9443661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus.
    Dal Forno G; Pietra C; Urciuoli M; van Amsterdam FT; Toson G; Gaviraghi G; Trist D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1056-63. PubMed ID: 1602372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological actions of cholecystokinin.
    Crawley JN; Corwin RL
    Peptides; 1994; 15(4):731-55. PubMed ID: 7937354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of cholecystokinin (CCK 1) and serotonin (5-HT 3) receptors increases the discharge of pancreatic vagal afferents.
    Mussa BM; Sartor DM; Verberne AJ
    Eur J Pharmacol; 2008 Dec; 601(1-3):198-206. PubMed ID: 19026634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder.
    Adamec RE; Shallow T; Budgell J
    Behav Neurosci; 1997 Apr; 111(2):435-49. PubMed ID: 9106682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.